The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global in-vitro colorectal cancer screening tests market was valued at US$ 880.1 Million in 2021.
We expect the global in-vitro colorectal cancer screening tests market to exhibit a CAGR of 6.10% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective colorectal cancer surgeries to reduce the risk of the coronavirus infection upon medical equipment, thereby negatively impacting the global market for in-vitro colorectal cancer screening tests.
The rising demand for in-vitro colorectal cancer screening tests in early detection, developing treatment plans, preventing the spread of cancerous cells, etc., is primarily driving the global in-vitro colorectal cancer screening tests market.
Based on the product, the global in-vitro colorectal cancer screening tests market can be segmented into fecal occult blood tests, biomarker tests, and CRC DNA screening tests. Currently, fecal occult blood tests hold the majority of the total market share.
Based on the imaging type, the global in-vitro colorectal cancer screening tests market has been divided into colonoscopy, proctoscopy, CT scan, ultrasound, MRI, and PET scan. Among these, colonoscopy currently exhibits a clear dominance in the market.
Based on the end user, the global in-vitro colorectal cancer screening tests market can be categorized into hospitals, clinics, diagnostic laboratories, and others. Currently, diagnostic laboratories account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global in-vitro colorectal cancer screening tests market include Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG, and Sysmex Corporation.
Dental Handpieces Market by Product (Air-Driven Handpieces, Electric Handpieces, Hybrid Air-Electric Handpieces), Speed (High- Speed, Low-Speed), End-User (Dental Clinics, Hospitals, and Others), and Region 2023-2028
Inferior Vena Cava (IVC) Filter Market by Product (Retrievable IVC Filter, Permanent IVC Filter), Material (Non-Ferromagnetic Materials, Ferromagnetic Materials), Application (Treatment Venous Thromboembolism (VTE), Prevent Pulmonary Embolism (PE), and Others), End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at